Your browser doesn't support javascript.
loading
TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.
Chung, Yoo-Ri; Kim, Jong Wan; Song, Ji Hun; Park, Aram; Kim, Min Ho.
Afiliação
  • Chung YR; Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Kim JW; Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Song JH; Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Park A; Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Kim MH; Department of Ophthalmology, Armed Forces Capital Hospital, Seongnam, Republic of Korea.
Retina ; 39(1): 134-142, 2019 Jan.
Article em En | MEDLINE | ID: mdl-29077604
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retina / Angiofluoresceinografia / Acuidade Visual / Corioide / Tomografia de Coerência Óptica / Coriorretinopatia Serosa Central / Bevacizumab Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retina / Angiofluoresceinografia / Acuidade Visual / Corioide / Tomografia de Coerência Óptica / Coriorretinopatia Serosa Central / Bevacizumab Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article